Synthesis and investigation of the anticancer effects of estrone-16-oxime ethers in vitro

Ágnes Berényi1, Renáta Minorics, Zoltán Iványi

  • 1Department of Pharmacodynamics and Biopharmacy, University of Szeged, Eötvös u. 6, H-6720 Szeged, Hungary.

Steroids
|November 7, 2012
PubMed

Insights

Newly synthesized estrone-16-oxime ethers show significant anticancer potential. These compounds induce apoptosis and cell cycle arrest in cancer cells, offering a promising foundation for new cancer therapies.

Area of Science:

  • Medicinal Chemistry
  • Oncology
  • Molecular Biology

Background:

  • Estrane derivatives are increasingly recognized for their potential as anticancer agents.
  • Estrone-16-oxime ethers represent a novel class of compounds with unexplored therapeutic applications.

Purpose of the Study:

  • To synthesize and evaluate the cytotoxic effects of 63 novel estrone-16-oxime ethers against human cancer cell lines.
  • To investigate the mechanism of action and cancer selectivity of the most promising compounds.

Main Methods:

  • Cytotoxicity was assessed using the MTT assay on HeLa, MCF7, and A431 cancer cell lines.
  • Mechanism of action was explored via cell cycle analysis, morphological studies, and 5-bromo-2'-deoxyuridine incorporation assays.
  • Cancer selectivity was evaluated against noncancerous MRC-5 fibroblast cells.

Main Results:

  • Four estrone-16-oxime ether derivatives exhibited significant cytotoxic activity.
  • These compounds induced apoptosis and cell cycle arrest at the G1-S phase transition.
  • Apoptosis was confirmed by caspase-3 activation and modulation of key regulatory proteins (retinoblastoma protein, CDK4, p16) at both mRNA and protein levels.

Conclusions:

  • Estrone-16-oxime ethers demonstrate potent anticancer activity and selectivity.
  • These compounds represent promising lead structures for the development of novel anticancer drugs.
  • The observed mechanism involves apoptosis induction and cell cycle regulation.